Insights Widest with the analysis, Proactive gives perspectives that others don't.

Champignon Brands Inc. - Psychedelics companies cheer as Canada grants landmark approval to four terminally ill patients to use psilocybin therapy

The decision should help open the door to greater and more rapid access to psilocybin therapy...

17 hours, 51 minutes ago
Deep dive

MindMed seeks to harvest the power of psychedelics to treat mental health...

The New York City-based company has several projects in various stages from planning to ongoing...

2 weeks ago
Deep dive

Cardiol Therapeutics is advancing its proprietary pharmaceutical cannabidiol...

The company is expecting significant growth in the second half of 2020 as it moves to launch its...

2 weeks ago

Proactive virtual event to showcase four companies on the fast track to...

Algernon Pharmaceuticals, Clean Seed Capital, MamaMancini's Holdings, and Alpine 4 Technologies...

2 weeks, 3 days ago

Small cap growth stocks in the spotlight at Proactive’s virtual event on July 21

Joining Proactive this time out are environmental engineering company BioLargo; life sciences...

3 weeks, 3 days ago


Antibe Therapeutics releases data from company’s Phase II placebo-controlled...

Antibe Therapeutics (CVE: ATE) CEO Dan Legault joined Steve Darling from Proactive Vancouver with new results from the company’s analysis of primary and secondary data from ATB-346’s recent placebo-controlled efficacy trial. Legault shares the data with Proactive and he also maps out the...

22 hours, 8 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.